SPOTLIGHT: Researchers encounter stem cell success, setback


Amid the high hopes that stem cell therapies could revolutionize the treatment of a number of diseases, researchers at the University of Rochester and Cornell have made a discovery in animal trials that has serious implications, both good and bad, for the possibilities of stem cell research. Report

Suggested Articles

Passage Bio filed to raise $125 million in its IPO. Now, it has outraised that goal by $91 million with a $216 million Wall Street debut.

The ruling reflects the judge’s belief that the FDA’s interpretation of the law on clinical trial reporting “is unlawful and must be set aside.”

Trutino will apply a platform designed to yield safer, more effective cytokines to the discovery of three oncology drugs for Boehringer.